News

Discover a study that showed that bariatric surgery increased survival in patients with cirrhosis compared to lifestyle ...
Malayalam film and television actor Vishnu Prasad passed away at the age of 49 in Kochi while he was undergoing treatment for ...
Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...
A global trial finds Wegovy and Ozempic significantly improve liver health in patients and treats those with advanced fatty ...
The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.
Semaglutide - the active ingredient in medications like Ozempic and WeGovy - is only FDA approved for Type-2 diabetes, but ...
Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...
A new drug application seeking the approval of ziftomenib was submitted to the FDA on April 8, 2025. This indication is for ...
The researchers then investigated how the metabolisms of treated mice changed. They found that the effect was caused by ...
Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...
A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...
Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...